Creighton University | Clinical Research Office

Research site
7710 Mercy Road, Suite 228, Omaha, Nebraska, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 103
Status: Active
Trial type: Interventional
Funder type: Industry

A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo
Locations recently updated

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older....

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Placebo
Drug: BI 1015550
Locations recently updated

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic...

Active, not recruiting
Lung Diseases, Interstitial
Drug: Placebo
Drug: BI 1015550

A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of bexotegrast (PLN-74809) for the treatment o...

Idiopathic Pulmonary Fibrosis
Drug: PLN-74809
Drug: Placebo

Trial conditions

Osteoporosis (8 trials)
Diabetes Mellitus (6 trials)
Fibrosis (6 trials)
Pulmonary Fibrosis (6 trials)
Vitamin D Deficiency (6 trials)
Chronic Renal Insufficie... (5 trials)
Idiopathic Pulmonary Fib... (5 trials)
Kidney Diseases (5 trials)
Type 1 Diabetes Mellitus (5 trials)
Rhinitis (4 trials)

And 74 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems